Head of Investor Relations
Canopy Growth Corp (CGC)Equibles does not estimate personal net worth.
Get an email with a short summary when Canopy Growth Corp publishes a filing, an earnings call transcript or a press release.
Get CGC alertsTyler Burns is recorded as Head of Investor Relations at Canopy Growth Corp (CGC). Tyler Burns has spoken on 16 earnings calls across 1 company, most recently for Canopy Growth Corp on June 15, 2026. Canopy Growth Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Canopy Growth Corp includes Luc Mongeau (CEO and Board Member), Judy A (Chairman), Judy Hong (CFO and Chief Accounting Officer) and 7 others.
“On our call today, we have Canopy Growth Chief Executive Officer Luke Mongeau and Chief Financial Officer Tom Stewart. Prior to the opening of Financial Markets today, Canopy Growth issued a news release announcing the financial results for its fourth quarter and fiscal year ended March 31, 2026.”
“On our call today, we have Canopy Growth Chief Executive Officer Luke Mongeau and Chief Financial Officer Tom Stewart. Before financial markets open today, Canopy Growth issued a news release announcing the financial results for our third quarter fiscal 2026 ended December 31st, 2025.”
“On our call today, we have Canopy Growth's Chief Executive Officer, Luc Mongeau; and Chief Financial Officer, Tom Stewart. Before financial markets opened today, Canopy Growth issued a news release announcing the financial results for our second quarter fiscal 2026 ended September 30, 2025.”
“On our call today, we have Canopy Growth's Chief Executive Officer, Luc Mongeau; and Interim Chief Financial Officer, Tom Stewart. Before financial markets opened today, Canopy Growth issued a news release announcing the financial results for our first quarter fiscal 2026, ended June 30, 2025.”
“On our call today we have Canopy Growth's Chief Executive Officer, Luc Mongeau; and Chief Financial Officer, Judy Hong. Before financial markets open today, Canopy Growth issued a news release announcing the financial results for our fourth quarter and fiscal year 2025 ended March 31, 2025.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
